✦ LIBER ✦

A High-Affinity Carbohydrate-Containing Inhibitor of Matrix Metalloproteinases

✍ Scribed by Vito Calderone; Marco Fragai; Claudio Luchinat; Cristina Nativi; Barbara Richichi; Stefano Roelens

Publisher: John Wiley and Sons
Year: 2006
Tongue: English
Weight: 207 KB
Volume: 1
Category: Article
ISSN: 1860-7179
DOI: 10.1002/cmdc.200600020

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A peptidomimetic inhibitor of matrix met

A peptidomimetic inhibitor of matrix metalloproteinases containing a tetherable linker group

✍ Yang Cao; Tristan I. Croll; Simone C. Rizzi; Gary K. Shooter; Helen Edwards; Kat 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 289 KB

## Abstract Successful wound repair and normal turnover of the extracellular matrix relies on a balance between matrix metalloproteinases (MMPs) and their natural tissue inhibitor of metalloproteinases (TIMPs). When overexpression of MMPs and abnormally high levels of activation or low expression o

ChemInform Abstract: Design and Synthesi

ChemInform Abstract: Design and Synthesis of Thiol Containing Inhibitors of Matrix Metalloproteinases.

✍ Cynthia A. Fink; J. Eric Carlson; Charles Boehm; Patricia McTaggart; Ying Qiao; 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 31 KB 👁 2 views

Design In Silico, Synthesis and Binding

Design In Silico, Synthesis and Binding Evaluation of a Carbohydrate-Based Scaffold for Structurally Novel Inhibitors of Matrix Metalloproteinases

✍ Marco Fragai; Cristina Nativi; Barbara Richichi; Chiara Venturi 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 148 KB 👁 2 views

Low molecular weight inhibitors of matri

Low molecular weight inhibitors of matrix metalloproteinases can enhance the expression of matrix metalloproteinase-2 (gelatinase A) without inhibiting its activation

✍ Erika H. M. Kerkvliet; Ineke D. C. Jansen; Ton A. M. Schoenmaker; Andy J. P. Doc 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 180 KB

## Background: In the current study, the authors investigated the effects of synthetic low molecular weight inhibitors of matrix metalloproteinases (mmps) on the expression and activation of mmp-2 in a three-dimensional tissue system. ## Methods: Rabbit periosteal explants were cultured with or w

Dosing and scheduling influence the anti

Dosing and scheduling influence the antitumor efficacy of a phosphinic peptide inhibitor of matrix metalloproteinases

✍ Vincent Dive; Kumari L. Andarawewa; Anne Boulay; Magdalini Matziari; Fabrice Bea 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 French ⚖ 290 KB

## Abstract The __in vivo__ disposition and antitumor efficacy of a newly developed phosphinic matrix metalloproteinase inhibitor (RXP03) were examined. RXP03 potently inhibits MMP‐11, MMP‐8 and MMP‐13, but not MMP‐1 and MMP‐7. Twenty‐four hours after i.p. injection into mice, most of the RXP03 was

Prinomastat, a hydroxamate inhibitor of

Prinomastat, a hydroxamate inhibitor of matrix metalloproteinases, has a complex effect on migration of breast carcinoma cells

✍ Elena I. Deryugina; Boris I. Ratnikov; Alex Y. Strongin 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 French ⚖ 301 KB

Membrane type-1 matrix metalloproteinase (MT1-MMP) and alphavbeta3 integrin have been directly implicated in tumor cell dissemination and metastasis. We have demonstrated that in the case of breast carcinoma MCF7 cells co-expressing MT1-MMP and alphavbeta3 integrin, the proteinase processes the pro-